A 35-year-old man with a history of severe penicillin anaphylaxis (angioedema, bronchospasm) presents with cellulitis of the leg due to Streptococcus pyogenes confirmed by culture. He is not pregnant and has no other drug allergies. What is the drug of choice for treatment?

Explanation

## Treatment of S. pyogenes Cellulitis in Severe Penicillin-Allergic Patient **Key Point:** In patients with severe (anaphylactic) penicillin allergy, clindamycin is the preferred agent for S. pyogenes soft-tissue infections because of excellent efficacy, tissue penetration, and safety profile. Cephalosporins are contraindicated due to cross-reactivity risk in anaphylaxis. ### Why Clindamycin is First-Line in Severe Penicillin Allergy 1. **Zero cross-reactivity**: Clindamycin is a lincosamide with a completely different beta-lactam-free structure; no cross-reactivity with penicillins or cephalosporins. 2. **Excellent S. pyogenes coverage**: Clindamycin is highly active against S. pyogenes, with resistance rates <5% in most regions. 3. **Superior tissue penetration**: Achieves high concentrations in soft tissue, bone, and abscess fluid. 4. **Oral and IV formulations**: Flexibility in dosing route based on severity. 5. **Anti-toxin activity**: Clindamycin suppresses toxin production (M protein, streptolysins), reducing inflammatory complications. ### Dosing Regimens for Cellulitis | Severity | Route | Dose | Duration | |----------|-------|------|----------| | **Mild-moderate** | Oral | 300–450 mg TID–QID | 7–10 days | | **Severe** | IV | 600–900 mg Q6–8H | 7–10 days (then switch to oral) | **High-Yield:** Clindamycin is preferred over vancomycin in severe penicillin allergy because it avoids the need for IV access, monitoring, and cost unless cellulitis is rapidly progressive or systemically toxic. ### Why Other Options Are Suboptimal #### Cephalexin (Option A) - **Contraindicated in anaphylactic penicillin allergy**: Cross-reactivity risk is ~1% overall, but in patients with anaphylaxis (IgE-mediated), the risk is unacceptably high. - **Clinical Pearl:** Cephalosporins are safe in non-anaphylactic penicillin allergy (e.g., rash, delayed reaction) but MUST be avoided in anaphylaxis. - **Warning:** This is a common exam trap — do not use cephalosporins in anaphylactic penicillin allergy. #### Vancomycin (Option C) - **Not first-line**: Vancomycin is reserved for: - Methicillin-resistant Staphylococcus aureus (MRSA) cellulitis. - Severe systemic infections (endocarditis, meningitis). - Penicillin-allergic patients with beta-lactam contraindication AND clindamycin resistance. - **Disadvantages**: Requires IV access, therapeutic drug monitoring (TDM), slower bactericidal activity, and higher cost. - **Not needed here**: S. pyogenes is susceptible to clindamycin; vancomycin is overkill. #### Fluoroquinolone (Option D) - **Inadequate for S. pyogenes**: Fluoroquinolones (e.g., levofloxacin) have poor activity against S. pyogenes and are not recommended for monotherapy. - **Risk of treatment failure**: Resistance and clinical failures have been documented. - **Reserved for**: Gram-negative infections, atypical pathogens, or respiratory infections. ### Decision Algorithm ```mermaid flowchart TD A[S. pyogenes infection confirmed]:::outcome --> B{Penicillin allergy?}:::decision B -->|No allergy| C[Penicillin V/G]:::action B -->|Allergy present| D{Anaphylaxis history?}:::decision D -->|No anaphylaxis| E[Cephalexin first-line]:::action D -->|Anaphylaxis| F[Clindamycin]:::action F --> G{Clindamycin resistance?}:::decision G -->|No| H[Oral or IV clindamycin]:::action G -->|Yes| I[Vancomycin IV]:::action ``` **Mnemonic:** **CLAN** — **CL**indamycin is the **AN**swer for **AN**aphylactic penicillin allergy.